Video

Dr. Yadav on Differences in Type 1 and Type 2 Uterine Cancer

Ghanshyam Yadav, MD, discusses the differences between type 1 and type 2 uterine cancer.

Ghanshyam Yadav, MD, resident physician, Baylor College of Medicine, discusses the differences between type 1 and type 2 uterine cancer.

Type 1 uterine cancer is associated with a favorable prognosis, says Yadav. Conversely, patients with type 2 cancer have a poor prognosis. Though rare, 50% to 70% of patients who have type 2 disease have extrauterine spread compared with 4% of patients with type 1 disease.

Type 2 cancer accounts for 40% of uterine cancer deaths despite the rarity of the disease, says Yadav.

Uterine cancer also tends to be resistant to chemotherapy. Therefore, there is a lot of work being done to develop novel targeted therapies, says Yadav. Targeting HER2 alterations could be a potential strategy as the target is expressed in a proportion of patients with uterine cancer, Yadav concludes.

Related Videos
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
Alex Herrera, MD
Roy S. Herbst, MD, PhD
Sheldon M. Feldman, MD
Laura J. Chambers, DO
Thomas Westbrook, MD
Massimo Cristofanilli, MD, attending physician, NewYork-Presbyterian Hospital; professor, medicine, Weill Cornell Medical College, Cornell University
Fred Saad, CQ, MD, FRCS, FCAHS, director, Prostate Cancer Research, Montreal Cancer Institute, Centre Hospitalier de l’Université de Montréal; full professor, Department of Surgery, Université de Montréal; uro-oncologist, Urology Department, University of Montreal Health Center
Ajay K. Nooka, MD, MPH, FACP